Genenta Science S.p.A.

NASDAQ:GNTA

3.94 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q2
Operating Activities:
Net Income -0.004-0.005-6.696-0.006-0.002-0.001-0.004-0.003-0.002-2.299-2.299
Depreciation & Amortization 000.02100000000
Deferred Income Tax 00-0.04200000000
Stock Based Compensation 0000000000.3750.375
Change In Working Capital 0.0020.001-1.2860-0.001-0.001-0.001-0-0.0010.6770.677
Accounts Receivables 00000000000
Change In Inventory 00000000000
Change In Accounts Payables 000000000-0.014-0.014
Other Working Capital 0.0020.001-1.2860-0.001-0.001-0.001-0-0.0010.690.69
Other Non Cash Items 000.4940.0010-0-0-0.0010.0010.0020.002
Operating Cash Flow -0.002-0.004-7.51-0.005-0.003-0.002-0.005-0.004-0.002-1.245-1.245
Investing Activities:
Investments In Property Plant And Equipment -0-0-0.012-0-0-0-0-0-000
Acquisitions Net 00000000000
Purchases Of Investments 00-9.89600000000
Sales Maturities Of Investments 00000000000
Other Investing Activites 0.004-0.005-0.00500000000
Investing Cash Flow 0.004-0.005-9.908-0-0-0-0-0-000
Financing Activities:
Debt Repayment 00000000000
Common Stock Issued 00.00100000007.5437.543
Common Stock Repurchased 000000-00000
Dividends Paid 00000000000
Other Financing Activities 000000.029-00.0010-0.159-0.159
Financing Cash Flow 000000.029-00.00107.3847.384
Other Information:
Effect Of Forex Changes On Cash -0-0000000000
Net Change In Cash 0.006-0.012-17.418-0.002-0.0010.013-0.002-0.001-0.00112.27812.278
Cash At End Of Period 0.0063.69412.216-0.0020.0350.0370.0110.0150.01820.14120.141